The FDA just approved a new sleeping pill – the second in a class that works by a novel mechanism – a dual orexin receptor antagonist.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
